Corcept Therapeutics Incorporated (CORT) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Corcept Therapeutics Incorporated (CORT) closed at USD 116.23 on 2026-10-14, a change of +62.4 % over the past year, with a market capitalization of USD 12.26B.

Corcept Therapeutics Incorporated recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Corcept Therapeutics Incorporated key figures

Previous close

USD 116.23 (2026-10-14)

1-year change

+62.4 %

Market cap

USD 12.26B

Enterprise value

USD 11.96B

P/E ratio (trailing)

263.65

P/E ratio (forward)

25.74

EPS (trailing)

0.43

EPS (forward)

4.41

PEG ratio

0.81

Price to book

17.33

Revenue growth

31.7 %

Earnings growth

24.1 %

Dividend per share (trailing)

0.00

Short ratio

5.11

Employees

730

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Corcept Therapeutics Incorporated and compare it with other stocks.